HK

Het Kiritbhai Pujara

Active Director Designated Partner DIN 11664748
DIN 11664748 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Het Kiritbhai Pujara

Data last updated:

Het Kiritbhai Pujara is a Designated Partner at Srnh Hospitals Llp (since 2026).

DIN 11664748
Primary Designation Designated Partner
First Appointment 15 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Apr 20262026Active

Board colleagues of Het Kiritbhai Pujara

NameDINCompanyDesignation
Neil Dipakbhai Shah11664747Srnh Hospitals LlpDesignated Partner
Rashi Sumit Patel11664746Srnh Hospitals LlpDesignated Partner
Sumit Ashokkumar Patel11467371Srnh Hospitals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Srnh Hospitals Llp
Premium access

Shareholding and investment profile for Het Kiritbhai Pujara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Het Kiritbhai Pujara

Het Kiritbhai Pujara currently holds 1 directorship: Srnh Hospitals Llp (Designated Partner, since 15 Apr 2026).

Het Kiritbhai Pujara was first appointed on 15 Apr 2026 as Designated Partner at Srnh Hospitals Llp.

The current boards of Het Kiritbhai Pujara's companies include Neil Dipakbhai Shah (Srnh Hospitals Llp), Rashi Sumit Patel (Srnh Hospitals Llp), Sumit Ashokkumar Patel (Srnh Hospitals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available